Respiratory trends and challenges for 2023
What are some of the challenges the industry is currently facing and what might be driving future respiratory drug delivery developments? These were the questions we put to industry experts at the Drug Delivery to the Lungs (DDL) annual conference, as part of an informal poll to get a feel for the latest respiratory trends.
We asked for responses to six questions, ranging from the challenges that companies face in the early and late stages of their developments, to the factors that will most strongly influence future respiratory device development and what people would be willing to sacrifice (if anything) to make their devices more sustainable. The survey had 50 respondents across the three days, including representatives from a number of leading pharmaceutical and respiratory drug delivery organisations. Here are the results.